Physician profile
Kyle A Smith
NPI 1194081232
$47,591.82
in general payments reported to CMS, 2019-2025
16 companies · $9,989 in 2025
The $9,989 reported for 2025 was more than what 85% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,385 · 2020: $2,242 · 2021: $1,167 · 2022: $13K · 2023: $11K · 2024: $1,881 · 2025: $9,989.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $17K · Travel and Lodging: $3,724 · Food and Beverage: $1,638.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $17,100.00 |
| Travel and Lodging | $3,724.33 |
| Food and Beverage | $1,638.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $33,246.04 | 2019-2025 | Elsa, Sable, Excelsiusgps Robotic Navigation System |
| Xtant Medical INC | $9,160.23 | 2022-2024 | |
| Medtronic USA, INC. | $2,089.43 | 2019 | |
| Medical Device Business Services, INC. | $972.27 | 2019 | |
| Nuvasive, INC. | $442.59 | 2019-2023 | Simplify Cervical Artificial Disc |
| Eko Health, INC. | $379.00 | 2021 | |
| Boston Scientific Corporation | $366.11 | 2024-2025 | Wavewriter Alpha Prime 16 |
| Medtronic, INC. | $251.18 | 2021-2025 | Inceptiv |
| Depuy Synthes Sales INC. | $249.32 | 2019 | |
| Providence Medical Technology, INC. | $146.54 | 2020-2021 | |
| Orthofix Medical, INC. | $107.45 | 2022 | |
| Stryker Corporation | $95.51 | 2019-2020 | |
| Solventum Corporation | $27.96 | 2025 | Prevena |
| Argenx US, INC. | $26.22 | 2025 | Vyvgart Hytrulo |
| Biohaven Pharmaceutical Holding Company LTD. | $17.19 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $14.78 | 2024 | Senza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.